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ABSTRACT
Methyl Jasmonate and Cis Jasmone Induce Apoptosis in PC-3 and LNCaP
Prostate Cancer Lines
by
Madhavi Bathina
Dr. Stephen W. Carper, Examination committee chair 
Professor of Biochemistry 
University of Nevada, Las Vegas
Methyl jasmonate (MJ) and cis jasmone (CJ), lipid-derived plant stress 
hormones, were studied for their effects against both hormone dependent 
(LNCaP) and hormone independent (PCS) human prostate cancer cell lines. Both 
2 mM MJ or CJ inhibited the growth of the cell lines. An alamar blue assay was 
used to determine IC50 values for MJ and CJ in both cell lines at 24 hrs, 48 hrs 
and 72 hrs. At 24 hrs the MJ IC50 values were 2.25 and 2.05 while the CJ values 
were 3.00 and 1.25 in the PCS and LNCaP lines respectively. Cell cycle analysis 
revealed that MJ and CJ induced apoptosis in both cell lines as well as activated 
caspase-3. An in vitro assay showed that MJ and CJ did not significantly inhibit 
either 5-lipoxygenase or 15-lipoxygenase. 5-HETE was able to stimulate cell 
growth in the presence or absence of MJ in both the cell lines.
Ill
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CHAPTER 1 
INTRODUCTION
The male sex hormones called androgens are involved in the growth and 
development of the prostate gland, an endocrine gland supporting male 
reproductive system. Prostate cancer is usually an adenocarcinoma, a cancer of 
the epithelial cells which compose the inner lining of endocrine glands. Prostate 
cancer is typically a slow growing cancer. Prostate cancer cells can metastasize 
to the lymph nodes, bones and other organs [1]. Cancer occurrence and the 
death rates vary among racial and ethnic groups. African American men have a 
24% higher prostate cancer incidence rate than Caucasians. Prostate cancer 
death rates in African American men are more than twice the rates in Caucasian 
men [2]. The estimated prostate cancer cases in 2006 will be 234,460 and the 
estimated prostate cancer deaths will be 27,350 [3]. Prostate cancer is the 
second most common cause of cancer death among men aged 80 years and 
older [3].
Prostate cancer can be treated in several different ways. Since 
testosterone is the most important male sex hormone that influences the 
behavior of the prostate gland and prostate cancer, its removal or inhibition can 
effectively slow down the growth of prostate cancer [4]. The major disadvantage
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
of hormonal therapy is that the prostate cancer cells eventually become resistant 
to hormonal therapy. Both radiation therapy and chemotherapy are used to treat 
prostate cancer. These treatment methods are not totally effective because they 
yield too many side effects, and sometimes the cancer cells grow back. The 
treatment options available for prostate cancer patients are considered to be 
ineffective, because, such treatment methods designed to kill cancer cells are 
dangerous to healthy cells [5]. Therefore, research is on going to discover new 
treatment methods and new agents that directly and selectively kill human cancer 
cells while leaving the healthy cells untouched.
Several plant compounds have been discovered in recent years that show 
cytotoxic effects against various human cancer cells. A number of plant stress 
hormones have been shown to suppress the proliferation and induce apoptosis in 
various human cancer cells [6]. Further research is required to understand the 
properties and their mode of action on cancer cells. Jasmonates are among such 
compounds.
Cell death can occur in two different ways, necrosis or apoptosis. Cell 
death due to injury such as exposure to toxic chemicals or mechanical damage in 
which the cell ruptures open is known as necrosis [7, 8]. Another form of cell 
death is programmed cell death or apoptosis. In apoptosis, the cells shrink; the 
chromatin in the nucleus condenses / degrades and mitochondria release 
cytochrome c [9]. Apoptosis is an evolutionarily conserved process. Apoptosis is 
required for normal development. During development of an organism the 
surplus cells are eliminated by apoptosis. For example, the establishment of
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synapses between neurons in the brain requires the surplus cells be eliminated 
by apoptosis. Cells of the immune system such as cytotoxic T lymphocytes kill 
virus-infected cells by inducing apoptosis [19].
The central component of apoptotic machinery is a proteolytic system 
involving a family of proteases known as caspases. To date, 14 caspases have 
been identified in mammals [20]. Caspases are intracellular cysteine proteases 
that cleave certain proteins after specific aspartic acid residues [21]. The 
precursor forms of caspases are expressed as proenzymes, consisting of three 
domains: an NH2-terminal domain, a large subunit and a small subunit. The 
active forms of caspases are generated by cleavage between the domains to 
liberate one large and one small subunit, which associate to form an active 
enzyme. The NH2 terminal domain is involved in the regulation of activation of 
caspases [19]. Caspases can be grouped in to three different categories: initiator 
caspases (caspases-2, -8, -9, -10), apoptotic executioners (caspases-3, -6, -7) 
and cytokine processors (caspases-1, -4, -5, -13). Initiator caspases activate or 
cleave the effector caspases, which degrade or activate other cellular proteins.
Apoptosis can occur by several different pathways (Figure 1, page 5). The 
death ligands such as Fas-L, when bound to the cell surface receptors induce the 
caspase cascade [10]. Apoptosis can also be induced through a mitochondrial 
pathway [10]. During the caspase cascade inactive forms of caspases are 
converted to active forms [10]. The initiator caspases that are first activated in the 
cascade are caspase-8 and caspase-9 [11]. Fas-L leads to the activation of 
caspase-8, which activates the apoptotic executioners like caspase-3 and
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caspase-7 [12]. Cytochrome c is released from mitochondria when the 
mitochondrial pathway is activated during apoptosis. Cytochrome c associates 
with Apaf-1 (apoptotic protease activating factor-1) and caspase-9 to form the 
“apoptosome” [22]. Apaf-1 processes procaspase-9 to an active form. Active 
caspase-9 initiates the caspase cascade involving other downstream 
executioners like caspase-3 and -7 [23]. Mammalian caspase-3 plays important 
and specific roles in apoptosis, and is important for cell shrinkage, chromatin 
condensation and DNA fragmentation [24, 13]. The proteolytic activity of these 
caspases leads to digestion of structural proteins and cleavage of a broad range 
of cellular targets that are essential for cell survival, chromosomal degradation 
and phagocytosis of the cell [25]. Caspase-3, -6 and -7 are involved in the 
cleavage of DNA repair enzyme poly (ADP-ribose) polymerase, whose cleavage 
is required for apoptosis induction [25].
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Fig 1 : The caspase cascade. C3=caspase 3, C7= caspase 7, C8=caspase 8 and 
C9=caspase 9. Cyt= cytochrome c and Apaf = apoptosis protease activating 
factor. Caspases in circles are in the procaspase form while the caspases in the 
crescents are in the active form. Adapted from ref. [12].
Jasmonates are plant stress hormones, found in a wide variety of plants. 
Jasmonates are lipid derived compounds formed from linolenic acid, a 18-0 fatty 
acid. Jasmonates play an important role in gene regulation in response to 
wounding, defense against pathogens, metabolic activities, reproduction, etc.
[14]. Jasmonic acid biosynthesis begins with linolenic acid (see figure 2). The 
most important enzyme involved in Jasmonic acid biosynthesis is lipoxygenase. 
Oxygenation of linolenic acid by lipoxygenase gives 13-hydroperoxylinolenic 
acid, which is then acted upon by the enzyme hydroperoxide dehydrase to give
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12,13-epoxy-linolenic acid, which undergoes cyclization by alleneoxide cyclase to 
yield the cyclopentanone derivative, 12-oxo-phytodienoic acid. 12-oxo- 
phytodienoic acid then undergoes reduction and three steps of p-oxidation to 
yield jasmonic acid [15].
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Fig;2 Biosynthetic pathway of jasmonic acid. Adapted from ref [15].
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Metabolic transformation of jasmonic acid yields methyl jasmonate (MJ) 
and cis jasmone (CJ) (figure 3). MJ and CJ are involved in different biological 
activities in plants. Jasmonates are involved in regulation of gene expression in 
response to certain pathogens and wounding [14].
COOCH:
a) Methyl Jasmonate
o
b) Cis-Jasmone
Fig:3 Chemical structures of Methyl Jasmonate and Cis-Jasmone
Recent research and growing evidence suggests that arachidonic acid (a 
20-carbon eicosanoid precursor) increases the progression of human prostate 
cancer [16]. Arachidonic acid metabolism yields prostaglandins, leukotrienes, 
and other eicosanoids [16]. As shown in figure 4 arachidonic acid metabolism 
through 5-lipoxygenase leads to the formation of 5-hydroxyeicosatetraenoic acid
8
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(5-HETE) (Figure 5, page 9). 5-HETE is important for the survival and 
progression of human prostate cancer cells [17].
Arachidonic acid
15-Lipoxygenase 5-Lipoxygenase Cyclooxygenase Epoxygenase
1 I
Prostaglandins Epoxymetabolites
15-HETE 5-HpHETE ^ Leukotrienes
I
5-HETE
Fig: 4 Arachidonic acid metabolism. Adapted from ref. [16].
.OH
COOH
Fig:5 Structure of 5-HETE.
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The aim of this study is to examine the effect of plant stress hormones, MJ 
and CJ on the growth and proliferation of human prostate cancer cells. MJ and 
CJ are downstream products of linolenic acid metabolism in plants, produced by 
lipoxygenase enzyme [15]. The growth and proliferation of human prostate 
cancer cells is dependent on the presence of 5-HETE, a metabolite, of the 
lipoxygenase pathway [18]. Since MJ and CJ are derived from a similar 
lipoxygenase pathway in plants, we hypothesize that, both MJ and CJ will be 
involved in feed back inhibition of 5-lipoxygenase in human prostate cancer cell 
lines (Figure 6, pagell). The two human prostate cancer cell lines used in this 
study are, LNCaP (hormone dependent) and PCS (hormone independent).
10
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Arachidonic acid
5-LO MJ and CJ
i  5-HETE
î Cell Death
Figure 6: Hypothesis, Inhibition of 5-lipoxygenase by methyl jasmonate (MJ) and 
cis jasmine (CJ).
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CHAPTER 2
LITERATURE REVIEW 
The present options for the treatment of prostate radiation therapy, 
chemotherapy, are all largely ineffective because of too many side effects and 
the cancer cell recurrence of growth. There is a need for the discovery of 
effective treatment methods which efficiently and selectively kill cancer cells 
without affecting normal healthy cells. In recent years use of plant compounds in 
treating cancer diseases like has increased because of the natural availability of 
these compounds, and their tendency to reduce the side effects and be less toxic 
than chemically synthesized compounds. Among such plant products, 
jasmonates have been tested for their ability to kill cancer cells [6j. Jasmonic acid 
formed from the precursor linolenic acid through the lipoxygenase pathway is 
involved in several physiological processes in plant growth and development
[15].
In recent years plant compounds such as perillyl alcohol (POH) and 
perillic acid (PA) have been tested for their effects on several types of human 
cancer cell lines including, human lung carcinoma, and human head and neck 
carcinoma [6]. Jasmonates have been shown to induce apoptosis in human 
leukemia, breast and prostate cancer cells [6]. Several other plant compounds
12
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such as silibinin and silymarin (extracts from the seeds of Silybum marianum) 
possess antiproliferative effects on human prostate cancer cells [26]. These plant 
compounds being tested were antiproliferative and induced apoptosis in cancer 
cell lines.
Another plant stress hormone, sodium salicylate (SA) showed 
antiproliferative effects on prostate, breast, lymphoblastic leukemia and 
melanoma human cancer cells [27]. Jasmonic acid (JA) and methyl jasmonate 
(MJ) were shown to induce apoptosis through caspase-3 activity in Molt-4 cells. 
JA and MJ decreased the proliferation and induced cell death in a dose 
dependent manner in hormone dependent human prostate cancer cell line, 
LNCaP [27].
Antiapoptotic protein family members such as Bcl-2 and BcI-Xl are 
involved in maintaining the integrity and stability of the mitochondrial membrane. 
Antiapoptotic proteins interact with the permeability transition pore complex 
within the mitochondrial membrane to inhibit membrane permeabilization (in turn 
inhibiting the release of cytochrome c) whereas the pro-apoptotic proteins such 
as Bax and BaK enhance the membrane permeabilization. Mitochondria are 
shown to be the best targets for the action of anticancer drugs [28].
The plant stress hormone MJ induced the release of cytochrome c from 
the mitochondria isolated from Molt-4 cells [29]. MJ has also been shown to 
activate MAPK (mitogen activated protein kinase) and induce differentiation in 
leukemia cells [30].
13
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Arachidonic acid has been shown to stimulate the proliferation of prostate 
cancer cells [31]. Arachidonic acid is metabolized by three different pathways: 
cyclooxygenase pathway, where it is metabolized to prostaglandins, epozygense 
pathway, where it is metabolized to epozymetabolites and lipoxygenase pathway, 
where it is metabolized to hydroxyderivatives of fatty acids and leukotrienes. 
Metabolites of the lipoxygenase pathway were found to be elevated in prostate 
cancer tissue [32]. In the lipoxygenase pathway 5-lipoxygenase(5-LO) is a key 
enzyme and has been shown to be elevated in human prostate cancer patients
[32] . Inhibition of 5-LO by specific inhibitors like MK886 induced apoptosis in 
human prostate cancer cell lines and resulted in the reduced production of 5- 
HETE [33]. The survival of both hormone-responsive and hormone-non 
responsive human prostate cancer cells can be dependent on 5-HETE [33]. 
Inhibition of the 5-HETE family of eicosanoids from arachidonic acid, triggered 
apoptosis in prostate cancer cell lines [17].
Arachidonic acid metabolism through the action of lipoxygenase enzymes 
lead to the formation of eicosanoid products such as 5-hydroxyeicosatetraenoic 
acid (5-HETE). This 5-HETE eicosanoid has been reported to be important for 
the growth of prostate cancer cells [33]. Specific inhibitors of 5-LO such as 
AA861 and MK886 resulted in the inhibition of growth stimulated by arachidonic 
acid [33]. But, the addition of a 5-LO product, 5-HETE, stimulated the growth of 
prostate cancer cells [33, 34]. It has been reported that metabolic conversion of 
arachidonic acid by the lipoxygenases is necessary to show its mitogenic activity
[33]. Recent studies have shown that the hydroxyderivatives of fatty acids and its
14
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metabolites (such as 5-HETE) but not the leukotrienes are involved in the 
proliferation of PC3 (hormone independent human prostate cancer cell line) [33]. 
Diets rich in fatty acids such as arachidonic acid stimulate the proliferation of 
human prostate cancer cells [33].
5-LO, a key enzyme in the lipoxygenase pathway and, has been the focus 
of intense research during the last few years. The eicosanoid 5-HETE, which is 
the down stream product of 5-LO was shown to be an essential survival factor for 
human prostate cancer cells [34]. But the molecular mechanisms involved in the 
5-HETE dependent survival of prostate cancer cells have not been elucidated. 
Six conserved histidine residues in the lipoxygenase enzyme that are important 
for the enzyme activity have been reported [36].
Stress activated protein kinases have been shown to play an important 
role in apoptosis. Inhibition of the 5-LO enzyme has been shown to activate JNK 
(c-jun N-terminal kinase), a stress activated protein kinase, in prostate cancer 
cells [35]. 5-HETE was also been shown to prevent the activation of JNK, which 
is important for apoptosis [35].
Jasmonates, especially methyl jasmonate was shown to induce cell death 
via induction of Bax/Bcl-Xs and activation of caspase-3 and -9 in A549 human 
lung adenocarcinoma cells [37]. This apoptosis was shown to be mediated by the 
production of reactive oxygen species [37].
Caspases play an important role in the cell death via apoptosis [12]. In 
various human cancer cells caspases are inactive and are inhibited [38]. In PC3, 
LNCaP and DU145 human prostate cancer cell lines, the caspases-1 and -3
15
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have been reported to be expressed at low levels, compared to normal cells.
[39].
Staurosporine, a protein kinase C inhibitor, induces apoptosis in LNCaP 
cells [40]. Recent research shows that, staurosporine induces the release of 
cytochrome c from the mitochondria to the cytosol, and activates the caspase-3 
and -7. The DNA repair enzyme poly (ADP) ribose polymerase (PARP) has been 
shown to be cleaved by caspase-3 and -7 in staurosporine treated LNCaP cells
[40]. These studies indicate that, activation of caspase-3 and -7 are important 
events during apoptosis in LNCaP cells.
16
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CHAPTER 3
3.1 MATERIALS
3.1.1 Chemicals and Reagents 
Methyl jasmonate [ methyl 3-oxo-2 ( 2-pentenyl ) cyclopentaneacetic acid ]
, cis-Jasmone [ 3-oxo-2 ( 2-pentenyl ) cyclopentane ] ,  and propidium iodide (PI) 
and 5-HETE (5-Hydroxy-eicosatetraenoic acid) were purchased from Sigma 
Chemical Co., (St Louis, MO). AlamarBlue dye was purchased from BioSource 
International, (Camarillo, CA). BCA protein assay kit was purchase from Pierce, 
(Rockford, IL). Lipoxygenase inhibitor screening assay kit was purchased from 
Cayman chemicals, (Ann Arbor, Ml). Caspase-3 Activity Assay Fluorometric Kit 
and Ham’s F-12K medium was purchased from the American Type Culture 
Collection (ATCC, Manassas, VA). Fetal bovine serum (FBS) was purchased 
from Hyclone Laboratories, (Logan, LIT), penicillin/streptomycin (P/S) was 
purchased from Invitrogen Incorporated (Grand Island, NY). Stock solutions of
1.0 M methyl jasmonate and cis jasmone were prepared in dimethylsulfoxide 
(DMSO) and the aliquots were stored at -20°C prior to use.
3.1.2 Cells and cell cultures 
Hormone dependent (LNCaP) and hormone independent (PC3) human 
prostate adenocarcinoma cell lines were purchased from the American Type
17
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Culture Collection (ATCC, Manassas, VA). Both cell lines were cultured in Ham’s 
F-12K medium, which was supplemented with 10% FBS and 1% penicillin- 
streptomycin.
3.2 METHODS
3.2.1 Cytotoxicity Assay 
The cytotoxic effects of methyl jasmonate and cis-jasmone were evaluated 
using alamarBlue assay. The alamarBlue reagent has a redox indicator which 
exhibits both fluorescence and colorimetric change based on metabolic activity of 
cells. Metabolic activity or growth of cells results in chemical reduction of 
alamarBlue, i.e., the redox indicator in the alamarBlue changes from oxidized 
(non-fluorescent, blue) to reduced (fluorescent, red). The fluorescence can be 
measured with excitation wavelength at 530-560nm and emission wavelength at 
590 nm. Briefly, 5,000 cells/well were plated in 96-well plates and the plates were 
incubated overnight to allow cells to adhere and then treated with different 
concentrations (0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 mM) of MJ and CJ in 100 pi of 
medium for up to 72 hrs. The control cells received medium with DMSO (£0.1%, 
v/v). After exposure at the desired time periods, the treatment medium was 
aspirated off and replaced with 100 pi of fresh medium and 10 pi of alamarBlue 
in each well and the plates were incubated at 37 °C in a humidified, 5% CO2 
atmosphere for 3-4 hrs. Cell viability was assessed by Genios plate reader at 
530-560 nm excitation and 590nm emission wavelengths. Cell viability in the 
treatment groups was compared to the control.
18
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3.2.2 Colony Formation Assay (CFA)
The long-term effect of the methyl jasmonate and cis-jasmone on the 
proliferation of hormone dependent -  LNCaP cell line and hormone independent 
-  PC3 cell line was assessed by colony formation assay. Approximately 500 
cells/well were plated in 6-well plates and incubated overnight to allow the cells 
to adhere. The following day, the control wells received medium containing 0.1% 
DMSO and the treatment wells received media with 2 mM MJ and 2 mM CJ, 
respectively. The 6-well plates were incubated for 24 hrs. After the treatment 
period, the medium from all the wells was aspirated off and the cells were rinsed 
twice with sterile PBS (phosphate buffer saline) and once with fresh medium. 
Fresh medium was added to all the wells of the 6-well plates and the cells were 
grown for 10-14 days. The plates were observed under the microscope every 
other day to check cell growth. At the end of the desired time period, the medium 
was aspirated off and the cells washed with sterile PBS and then stained with 
crystal violet (0.5 g/IOOmI in 95% ethanol). The colonies (each colony containing 
> 50 cells) were counted in control wells and treatment wells. The number of 
colonies formed in the treatment group was compared to controls.
3.2.3 Proliferation Assay 
The effect of MJ and CJ on the proliferation of human prostate 
adenocarcinoma cell lines was assessed by proliferation assay. Approximately
100,000 cells were plated in each pi 00 plate. The cells were allowed to adhere 
by incubating overnight at 37°C in the incubator. The experiment was divided into 
three groups: control group, “24-hrs drug exposure and wash-off group and
19
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treatment group (10 plates In each group). Following adhesion the control group 
received 0.1% DMSO. The wash-off group and the treatment group received 2 
mM MJ or CJ. The plates were incubated for 10 days (10 plates in each group). 
After one-day, one p i00 plate from each of the three groups (control, wash-off 
and treatment) was harvested with trypsin-EDTA and the number of live and 
dead cells was counted separately using a hemocytometer. The remaining nine 
plates from the wash-off group were rinsed with PBS twice and with fresh 
medium once. Fresh medium was added to all the plates of the wash-off group 
and incubated. After two days of exposure, one plate from each group: control, 
wash-off and treatment, were harvested using trypsin-EDTA and live and dead 
cells were counted using a hemocyotmeter. This procedure was followed 
everyday for up to 5 days and then the cells were harvested and counted every 
other day (7*^ , 9*^ , 11‘ ,^ 13*^ , and 15* day). The effect of MJ and CJ on the growth 
and proliferation of LNCaP and PC3 cell lines was assessed by comparing the 
number of live and dead cells in the wash-off and treatment groups.
3.2.4 Lipoxygenase Assay 
The effect of MJ and CJ on 5-lipoxygenase and 15-lipoxygenase was 
assessed by an in vitro assay, using a lipoxygenase inhibitor screening assay kit, 
purchased from Cayman Chemicals. This assay detects and measures the hydro 
peroxides produced in the lipoxygenation reaction using a purified lipoxygenase. 
This in vitro assay was carried out in a 96-well plate. The blank wells received 
100 pi of the assay buffer, control wells received 90 pi of 5-lipoxygenase or 15- 
lipoxygenase enzyme with 10 pi of assay buffer and the treatment wells received
20
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90 pi of 5-lipoxygenase or 15-lipoxygenase enzyme with 10 pi of the inhibitor (MJ 
or CJ). The concentrations of MJ and CJ used in this assay were 10 mM, 50 mM, 
100 mM and 500 mM. The reaction was initiated by adding 10 pi of arachidonic 
acid (substrate) to all the wells. The 96-well plate was kept on shaker for 5min. 
lOOpI of chromogen was added to all the wells to stop the enzyme catalysis and 
to develop the reaction. The plate was again kept on a shaker for 5 min. The 
absorbance was then read at 490-500 nm using a plate reader. The percent 
inhibition of 5-lipoxygenase and 15-lipoxygenase enzymes by MJ and CJ were 
plotted.
3.2.5 Assay With 5-HETE 
The effect of MJ in presence of 5-HETE was evaluated in cytotoxicity 
assay using alamarBlue. Both PC3 and LNCaP cell lines were tested. Briefly,
5,000 cells/well were plated in 96-well plate and the plate was incubated 
overnight to allow the cells to adhere. First treatment group received 2 mM MJ in 
100 ul of medium; the other treatment group received 2 mM MJ with 1000 nM of 
5-HETE and the third treatment group received 1000 nm 5-HETE alone, for 48 
hrs. The control cells received medium with DMSO (£0.1% v/v). After exposure to 
desired time period, the treatment medium was aspirated off and replaced with 
100 ul of fresh medium and 10 ul of alamarBlue in each well and the plate was 
incubated at 37°C in a humidified, 5% CO2 atmosphere for 3-4 hrs. Cell viability 
was assessed by Genios plate reader at 530-560 nm of excitation and 590 nm of 
emission wave lengths. Cell viability in the treatment groups was compared to 
the control.
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3.2.6 Apoptosis Assays
3.2.6.1 Flow Cytometry DNA Analysis using Propidium Iodide Stain 
To assess the effect of MJ and CJ on cell cycle progression and 
apoptosis, cell cycle analysis was carried out using flow cytometry. One million 
PC3 cells and LNCaP cells were cultured in 100 mm tissue culture plates. The 
cells were allowed to adhere to the bottom by incubating overnight. The following 
day, the control plates received 0.1% DMSO and the treatment plates received 1 
mM, 2 mM and 3 mM MJ and CJ. The plates were incubated for 24 hrs, 48 hrs 
and 72 hrs. At the end of exposure time the cells were harvested from the control 
plate and the treatment plate using trypsin-EDTA and centrifuged at 850 rpm for 
5 minutes. The supernatant was aspirated off and the pellet was resuspended in 
appropriate volume of fresh media. Total number of cells was counted in the 
control and treatment groups using a coulter counter. From the control and the 
treatment group, a cell suspension containing 500,000 cells was centrifuged. 
The pellet was resuspended in an appropriate volume of PBS, and centrifuged at 
850 rpm for 5 min. The supernatant was removed and to the cell pellet 100 ul of 
the PBS was added and 900 ul of ethanol (95%) was added while vortexing. The 
samples were transferred to +4 °C refrigerator.
For DNA content analysis, the ethanol fixed cells were centrifuged at 850 
rpm for 5 min to remove ethanol supernatant. To the pellet, DNA staining 
solution (0.1% Triton-X: 1 mg/ml RNase: 150 pg/ml PI in 1:1:1 ratio by volume) 
was added and the samples were incubated in the dark at room temperature for 
30 minutes. The stained cells were used for the flow assay. Both the area and
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width of the fluorescence pulse were measured using Cell Quest acquisition 
software (Becton Dickinson, San Jose, CA). Ten thousand events were acquired 
and the percentage of cells in G1, S and G2/M phases and apoptosis were 
determined by ModFit analysis, using Mod Fit LT version 3.0 analysis software 
(Verity Software House, Inc., Topsham, ME).
3.2.6.2. Caspase-3 Fluorometric Assay
To determine whether or not the caspase cascade is activated by MJ in 
PC3 cells, caspase-3 fluorometric assay was performed. The caspase-3 activity 
assay detects the caspase-3 activity in the cell lysates. Cell lysates were 
prepared from 2 mM MJ treated PC3 cells. Briefly, 5 million cells were cultured in 
100mm tissue culture plates. Cells were allowed to adhere to the bottom of the 
plates by incubating overnight. Following day, the control plate received 0.1% 
DMSO and the treatment plates received 2 mM MJ. The plates were incubated 
for 3 hrs, 6 hrs, 12 hrs, and 24 hrs. At the end of the exposure time, the cells 
were harvested using trypsin-EDTA and centrifuged at 850rpm for 5 minutes. 
The cell pellet was resuspended in an appropriate volume of fresh media and the 
numbers of cells were counted in control and treatment group using a 
hemocytometer. The cell suspension was again centrifuged at 850rpm for 5min. 
The pellet is washed with PBS, centrifuged at 850rpm and resuspended in 1 ml 
of PBS. The cell suspension was transferred to microfuge tubes and centrifuged 
at 10OOrpm at 4°C for lOmin. The supernatant was removed and the pellets 
were stored at -80°C. Cell lysates were prepared from the pellets using the
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sample buffer/extraction buffer provided in the kit. Both positive and negative 
controls were included according to the instructions provided in the kit.
Caspase-3 assay was performed in a 96-well plate. The blank wells 
received 50 pi of the sample/extraction buffer. The control cell lysate (50 ul) was 
added to the control well and 50 pi of each of the treatment cell lysates (prepared 
from PC3 cells treated with 2 mM MJ for 3 hrs, 6 hrs, 12 hrs, 24 hrs and the 
lysates prepared from PC3 cells treated with 2 mM CJ for 3 hrs, 6 hr, 12 hrs and 
24 hrs) were added to the test wells. The assay buffer (50 ul) was added to all 
the wells including blank and control. Caspase-3-substrate (10 ul) conjugate was 
added to all the wells. The plate was read immediately after the addition of 
substrate, using a fluorescent plate reader at 360nm excitation and 465 nm 
emission (0 hr reading) and then the plate was incubated at 37°C and read every 
30 minutes. A total of 8 readings were taken (0 hr, 30 min, 1 hr, 1.5 hr, 2.0 hr, 2.5 
hr, 3.0 hr and 3.5 hrs reading). The data was expressed as relative fluorescence 
units with respect to the control.
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CHAPTER 4
RESULTS AND DISCUSSIONS 
The effects of methyl jasmonate (MJ) and cis jasmone (CJ) were tested on 
both PC3 and LNCaP prostate cancer cells in culture. Results with a dye 
exclusion (proliferation) assay showed both MJ and CJ can inhibit the growth of 
human prostate cancer cell lines. When exposed to 2 mM MJ, PC3 cell 
proliferation was decreased compared to the control as the time of exposure to 
the agent increased (Fig 7 panel A, page 35). When 2 mM MJ was washed-off 
after 24 hrs exposure in PC3 cells and supplemented with fresh media, no 
recovery of proliferation was observed. As expected the control (without MJ), 
showed increasing proliferation with time.
The effect of CJ was also tested on PC3 cells. These results were similar 
to that of MJ treatment on the PC3 cell line. As the number of days of exposure 
to CJ increased, the number of cells decreased (Fig 7 panel B, page 35). When 
CJ was exposed only for 24 hrs and the drug was washed away, and 
supplemented with fresh media, no recovery of proliferation was observed. 
Control cells prolifered with time. These results indicate that both the plant stress 
hormones MJ and CJ induce cell death at 2 mM.
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MJ and CJ were also tested at 2 mM on the proliferation of hormone-dependent 
human prostate cancer cell line, LNCaP. As shown in the Fig 8, page 36, both 
MJ and CJ decreased the proliferation of LNCaP cells at 2 mM. As the number of 
days of exposure to MJ and CJ increased, proliferation decreased 
correspondingly. When either MJ (panel A) or CJ (panel B) were washed-off 
following a 24 hr exposure and LNCaP cells supplemented with fresh medium, 
the proliferation of the cells was not restored. In the control, the proliferation 
increased with time.
Alamar Blue assay was conducted to measure the cytotoxicity of MJ and 
CJ on both PC3 and LNCaP cells. Fig 9 (page 37) shows the cytotoxicity of these 
agents on the PC3 cell line. MJ inhibited the proliferation of PC3 (panel A) cells 
at all the concentrations tested (0.5 mM, 1.0 mM, 1.5 mM, 2.0 mM, 2.5 mM and
3.0 mM). The inhibition of proliferation was dose and time dependent. The 
concentration of the MJ that inhibits 50% proliferation of PC3 cells (Inhibitory 
concentration-IC5o%) at three different time points 24 hrs, 48 hrs, and 72 hrs were 
2.75 mM, 2.37 mM, 1.50 mM respectively (Table 1, Page 39). These results 
indicate that MJ is toxic to the PC3 cells and the cytotoxicity increases as the 
time of exposure to the cells increases. The ICso% concentrations decreased as 
the time of exposure to the agent increased.
The cytotoxicity of CJ was also tested on PC3 cells (Figure 9 panel B, 
page 37) at the concentrations: 0.5 mM, 1.0 mM, 1.5 mM, 2.0 mM, 2.5 mM and
3.0 mM. Viability in the treatment group was calculated as % viability compared 
to the control. The % viability in the treatment groups decreased as the
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concentration of the drug increased and as the time of exposure to the drug 
increased. The IC5o% concentrations for the CJ at three different time points 24 
hrs, 48 hrs and 72 hrs were observed to be 3.0 mM, 3.0 mM and 2.0 mM 
respectively (Table 1, page 39).
Both the jasmonates were tested for their cytotoxicity on the hormone 
dependent prostate cancer cell line LNCaP. The alamar Blue assay with MJ and 
CJ on the LNCaP cell line, indicated that LNCaP cell line is more sensitive to MJ 
and CJ compared to PC3 cell line, as indicated by the ICso% concentrations. The 
concentrations of MJ and CJ used were 0.5 mM, 1.0 mM, 1.5 mM, 2.0 mM, 2.5 
mM and 3.0 mM (Figure 10 page 38). MJ decreased the viability of the LNCaP 
cells compared to control (Figure 10 panel A) , in all the treatment groups with 
ICso% of 2.05 mM, 1.25 mM and 1.18 mM for 24 hrs, 48 hrs and 72 hrs 
respectively (Table 1, page 39). CJ was found to be more effective than MJ on 
LNCaP cell line (Figure 10 panel B). The effect of CJ on LNCaP cells was more 
pronounced at 72 hrs with ICso% of 0.62 mM. For 24 hrs and 48 hrs of exposure 
CJ induced cytotoxicity with ICso% of 1.25 mM and 0.75 mM respectively.
The alamar Blue assay using MJ and CJ on PC3 and LNCaP cell lines 
indicate that, both MJ and CJ are cytotoxic and cause a decrease in the 
proliferation of these cell lines. This inhibition of proliferation was dose and time 
dependent except for LNCaP cells treated with CJ which failed to show time 
dependence. At the highest concentration tested (3 mM) MJ or CJ, killed almost 
all the cells. The concentration of MJ and CJ which is near or slightly greater than
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the IC5o%, for both PC3 and LNCaP, was used in the further experiments, (i.e., 2 
mM MJ and 2 mM CJ were used).
The long term effects of the methyl jasmonate and cis jasmone were 
tested on the proliferation of PC3 and LNCaP cells, using a colony formation 
assay. Figure 11 page 40) shows the long term effect of MJ and CJ on PC3 cells 
(panel A). MJ (2 mM) inhibited the proliferation of PC3 cells by 79% and 2 mM 
CJ inhibited the proliferation by 79%.The cells were exposed to MJ or CJ for 24 
hrs, and the drug was then washed off and the cells were provided with fresh 
media. The cells were allowed to grow and form colonies for about 10-14 days. 
The number of colonies (>/= SOcells) formed in the treatment group are 
compared to the control. These results indicate that both MJ and CJ effectively 
inhibit the long term proliferation of PC3 cell line.
Colony formation assay with LNCaP cell line (Fig 11, panel B, page 40) 
showed that, MJ inhibited 83% of colony formation and CJ inhibited 87%. These 
results are consistent with the alamar blue assay, which showed that the LNCaP 
cell line is more sensitive to MJ and CJ than the PC3 cell line and CJ is more 
lethal to LNCaP cells compared to MJ.
Cell cycle analysis using flow cytometry was conducted using both MJ and 
CJ at 1 mM, 2 mM and 3 mM, to study the effects of these agents on cell cycle 
progression and apoptosis. The PC3 and LNCaP cells were exposed for 24 hrs, 
48 hrs and 72 hrs to MJ or CJ, PI stained and analyzed using flow cytometry. 
The values of the percentage of cells in each phase of cell cycle and apoptosis in 
both PC3 and LNCaP cells with MJ or CJ are shown in the appendix (Table 2-5,
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page, 53-56). Figure 12, page 45 shows the effect of 1 mM MJ, 2 mM MJ and 3 
mM MJ on cell cycle progression and apoptosis of PC3 cell line. When PC3 cells 
were exposed to MJ for 24 hrs, (panel A) 1 mM MJ caused an increase in G1 
population. S-phase arrest was observed in 48 hrs and 72 hrs of exposure to 2 
mM and 3 mM MJ (panel B and C).
Following 24 hrs exposure as the concentration of MJ increased, the 
percentage of apoptotic cells also increased. At 24 hrs 1 mM MJ induced 1.21% 
of apoptosis, 2 mM MJ and 3 mM MJ induced 7.32% and 11.23% apoptosis 
respectively (Figure 12, panel A).The control had only 0.87% of apoptosis. At 48 
hrs, 1 mM MJ, 2 mM MJ and 3 mM MJ induced 5.14%, 5.56% and 12.84% of 
apoptosis respectively, but the control also had 5% apoptosis (panel B). The 
percentage of apoptosis increased at 72 hrs with 3 mM MJ (13.37%). At 72 hrs, 1 
mM and 2 mM MJ induced 11.57% and 15.18% apoptosis while the control had 
7.37% apoptosis (panel C). These results indicate that MJ causes cell death in 
PC3 cells by inducing apoptosis and cell cycle arrest at S-phase (as observed 
with 2 mM and 3 mM MJ treatment at 48 hrs and 72 hrs).
Figure 13, page 42 shows the effect of 1 mM, 2 mM and 3 mM CJ on cell 
cycle progression and apoptosis in PC3 cells. All the three different 
concentrations of CJ tested, induced cell cycle arrest at S-phase and also 
induced apoptosis in a dose dependent manner. At 24hrs of exposure to CJ, 1 
mM, 2 mM and 3 mM treatment groups showed 65.05%, 70.91% and 62.45% of 
cells in the S-phase, compared to the control which showed only 49.42% of cells 
in the S-phase (panel A). The percentage of cells that progressed to G2/M
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phase, in the treatment groups decreased correspondingly. The control showed 
18.35% of cells in G2/M phase whereas, 1 mM, 2 mM and 3 mM CJ treatment 
groups showed only 8.50%, 0.35% and 0.88% of cells in G2/M phase.
At 48hrs of exposure to CJ, similar results were obtained. All the three 
different treatment groups showed 68.95%, 66.25% and 63.63% of cells in S- 
phase (Figure 13, panel B). The control showed only 27.38% of cells in the S- 
phase. The percentage of cells that progressed to G2/M phase decreased. 1 
mM, 2 mM and 3 mM CJ had, 0.36%, 0.33% and 0.57% of cells in G2/M phase, 
whereas control group had 30.81% of cells in G2/M phase.
Similar results were obtained at 72 hrs exposure to CJ (Figure 13, panel 
C). All three concentrations of CJ, 1 mM, 2 mM and 3 mM, induced cell cycle 
arrest at the S-phase. The control showed 30.62% of cells in the S-phase, 
whereas the three treatment groups showed 64.26%, 57.62% and 61.34% of 
cells in the S-phase of cell cycle, which indicates cell cycle arrest at S-phase. 
The control group showed 24.36% of cells in the G2/M phase. 1 mM CJ, 2 mM 
CJ and 3 mM CJ treatment groups showed only 4.34%, 12.73% and 0.45% of 
cells in G2/M phase. This indicates poor progression of cells from S-phase to 
G2/M phase, in the CJ treatment groups.
There was an increase in the percentage of apoptotic cells in the CJ 
treatment groups compared to the control. At 24 hrs of exposure, an increase in 
the concentration of CJ increased the percentage of apoptotic cells compared to 
the control. 1 mM CJ, 2 mM CJ and 3 mM CJ induced 1.93%, 1.93% and 11.94% 
of apoptosis compared to the control which had only 0.07% of apoptotic cells. At
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48 hrs of exposure CJ induced 4.17%, 4.68% and 10.92% of apoptosis in the 
three treatment groups respectively. Control at 48hrs showed 1.57% of 
apoptosis. As the time of exposure to CJ increased, the number of apoptotic cells 
increased. This can be clearly viewed at 72 hrs of exposure to CJ. At 72 hrs 3mM 
CJ induced 23.66% of apoptosis. 1 mM and 2 mM CJ induced 4.80% and 5.57% 
apoptosis respectively compared to control, which had 2.37% of apoptotic cells.
Figure 14, page 43 shows the effect of MJ at 1 mM, 2 mM and 3 mM, on 
LNCaP cell line. At all the three concentrations tested no cell cycle arrest at any 
particular phase was observed. The percentage of apoptotic cells in the 1 mM, 2 
mM and 3 mM MJ treatment groups, at 24 hrs were 3.69%, 2.11% and 10.41% 
(panel A). The control showed 0.45% apoptotic cells. At 48 hrs, the percentage of 
apoptotic cells were 1.43%, 5.95% and 6.93% in 1 mM, 2 mM and 3 mM 
treatment groups respectively (panel B). While the control showed 1.46% 
apoptosis. At 72 hrs of exposure to MJ (panel C), the percentage of apoptotic 
cells were 3.2%, 1.62% and 4.46% at 1 mM, 2 mM and 3 mM MJ treatment 
groups respectively, whereas the control has only 0.39% of apoptotic cells.
Figure 15, page 44 shows the effect of CJ, at 1 mM, 2 mM and 3 mM on 
the LNCaP cell line, at three different time periods, 24 hrs, 48 hrs and 72 hrs. At 
all the three concentrations tested, no cell cycle arrest at any particular phase 
was observed. But a dose response was observed in the percentage of apoptotic 
cells in all the three treatment groups. At 24 hrs, with 0 mM CJ the percentage of 
apoptosis was only 0.23%, which increased to 0.75%, 5.73% and 32.77% with 1 
mM, 2 mM and 3 mM CJ treatments respectively (panel A). At 48 hrs, with 0
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mM CJ the percentage of apoptosis was 0.26%, which increased to 1.67&, 
12.22% and 50.74% with 1 mM, 2 mM and 3 mM CJ treatments (panel B). At 72 
hrs with 0 mM Cj the percentage of apoptosis was only 0.14%, which increased 
to 6.40%, 9.00% and 52.61% with 1 mM, 2 mM and 3 mM CJ treatments (panel 
C).
We hypothesized that methyl jasmonate and cis jasmone inhibit the 5- 
lipoxygenase in arachidonic acid metabolism and cause a decrease in the 
production of 5-HETE eicosanoid, thereby increasing the cell death. Several 
studies on arachidonic acid metabolism and 5-HETE showed that, 5-HETE is 
essential for the survival of human prostate cancer cell lines [35]. To test this 
hypothesis we performed an in vitro assay, to study the effects of MJ and CJ on 
5-Lipoxygenase (5-LO) and 15-Lipoxygenase enzymes (15-LO).
Fig 16, page 45 shows the in vitro lipoxygenase enzyme assay with MJ 
and CJ. The concentrations of MJ and CJ used in this study were 10 mM, 50 
mM, 100 mM and 500 mM. The percentage activity of 5-lipoxygenase with both 
MJ and CJ was around 80% at 10 mM concentration i.e., MJ and CJ at 10 mM 
concentration could inhibit only <20% of 5-lipoxygenase activity in vitro (panel
A). The percentage activity of 15-lipoxygenase with 10 mM MJ was ~65% (panel
B). While 10 mM CJ did not inhibit the 15-lipoxygenase (panel B). These results 
indicate that MJ and CJ did not inhibit the 5-lipoxygenase enzyme activity in vitro. 
We then tested the activity of 5-lipoxygenase enzyme with different 
concentrations of MJ. Lower concentrations of MJ were tested -  5 mM, 10 mM, 
30 mM and 50 mM as shown in the figure 17, page 46, Inhibition of 5-
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lipoxygenase with 5 mM MJ was only -20%. At the concentrations 1 mM, 2 mM 
and 3 mM (which we used for other assays in culture), only -5% inhibition of 5- 
lipoxygenase by MJ was observed.
In order to test whether MJ acts downstream of 5-HETE in the arachidonic 
acid metabolic pathway, we performed alamar Blue assay with 0.001 mM 5- 
HETE. As shown in the figure 18, page 47, panel A, treatment with 0.001 mM 5- 
HETE increased the viability of PC3 cells by -30%. Treatment with 2 mM MJ 
alone decreased the percent viability by >75%. In the other treatment group 
where 0.001 mM 5-HETE was added together with 2 mM MJ, 5-HETE still 
increased the viability of PC3 cells by -30%.
Similar results were obtained with the LNCaP cell line. The treatment 
group with 0.001 mM 5-HETE alone increased the proliferation of LNCaP cells by 
-30% (panel B). 2 mM MJ alone decreased the viability by >60%. In the other 
treatment group, with 0.001 mM 5-HETE and 2 mM MJ, 5-HETE increased the 
viability of LNCaP cells by -30% even in the presence of 2 mM MJ.
We performed fluorometric assay for caspase activity, in PC3 cell line, to 
study whether apoptosis in the human prostate cancer cells occur though 
caspase activity, induced by Methyl Jasmonate.
We have analyzed the mechanism by which MJ and CJ induce apoptosis 
in PC3 lines. We tested whether MJ or CJ induced apoptosis involves caspase-3. 
Our data shows that both MJ and CJ induce apoptosis through activation of 
caspase-3, in PC3 cell line (Figure 19 and 20, page 48 and 49). Caspase-3 is 
one of the apoptotic executioners and plays an important role in cell shrinkage.
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chromatin condensation and DNA fragmentation [24]. Caspase-3 is involved in 
the cleavage of DNA repair enzyme poly (ADP-ribose) polymerase, which is 
required for apoptosis induction [25].
Cell lysates prepared from 2 mM MJ or CJ treatments for 3 hrs, 6 hrs, 12 
hrs and 24 hrs were used in this assay. This fluorometric assay detects the 
caspase-3 activity in the cell lysates, when incubated with caspase-3 substrate 
conjugate. The cell lysates were incubated with the caspase-3 substrate 
conjugate for 3.5 hrs, and the enzyme activity was read every half-hour, and the 
data was represented as relative fluorescence units of the enzyme corrected for 
any activity in the control.
Figure 19, page 48 shows that caspase-3 activity was induced in all the 
treatment groups (3 hrs, 6 hrs, 12 hrs and 24 hrs exposure to 2 mM MJ). The 
amount of product fluorescence increased with time. Among the different 
treatment groups 3 hr showed lowest activity while the 6 hr and 12 hr groups had 
the highest.
Figure 20, page 49 shows similar results of caspase-3 fluorometric assay, 
with 2 mM CJ on PC3 cell line. Again 3 hr treatment group had the least activity 
while the 12 hr group had the highest activity.
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Fig 7: Proliferation assay on PC3. 2 MJ and CJ induced cell death in PC3 cell line 
using dye exclusion assay. Cells were exposed to MJ or CJ for the time 
indicated. In another treatment group, cells were exposed for 24hrs, drug was 
then washed off and let grow for 15 days. The error bars represent the standard 
deviation of the means (n=4).
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Fig 8: Proliferation assay on LNCaP. 2 MJ and CJ induced cell death in LNCaP 
cell line using dye exclusion assay. Cells were exposed to MJ or CJ for the time 
indicated. In another treatment group, cells were exposed for 24hrs, drug was 
then washed off and let grow for 15 days. The error bars represent the standard 
deviation of the means (n=4).
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Fig: 9 Alamar blue assay on PC3. MJ and CJ inhibited the proliferation of PC3 
cells at the concentrations tested, using alamar Blue assay. PC3 cells were 
exposed to MJ and CJ for 24hrs, 48hrs and 72hrs. Error bars represent the 
standard deviation of the means (n=6).
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Fig10; Alamar blue assay on LNCaP. MJ and CJ Inhibited the proliferation of 
LNCaP cells at the concentrations tested, using alamar Blue assay. LNCaP cells 
were exposed to MJ and CJ for 24hrs, 48hrs and 72hrs. Error bars represent the 
standard deviation of the means (n=6).
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Table 1: IC50 values for MJ and CJ (mM) in PC3 and LNCaP cells
Cell line Agent 24hr 48hr 72hr
PC3 MJ 2.75 2.37 1.50
CJ 3.00 3.00 2.00
LNCaP MJ 2.05 1.25 1.18
CJ 1.25 0.75 0.62
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Fig 11: Colony Formation Assay, 2mM MJ and CJ inhibited the long term 
proliferation of PC3 cell and LNCaP cells. Cells were exposed to MJ and CJ for 
24hrs, then the drug was washed off, cells were supplemented with fresh media 
and let grow for 10-14days. The error bars represent the standard deviation of 
the means (n=4).
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Fig 12: Flow cytometry with MJ on PC3. MJ induced S phase block and 
apoptosis in PC3 cells, exposed to MJ for 24hr, 48hr and 72hr, PI stained and 
analyzed through flow cytometry.
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Fig 13: Flow cytometry with CJ on PC3. CJ induced S phase block and
apoptosis in PC3 cells, to CJ for 24hr, 48hr and 72hr, PI stained and analyzed 
through flow cytometry.
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Fig 14: Flow cytometry with MJ on LNCaP. MJ induced apoptosis in dose and 
time dependent manner in LNCaP cells, exposed to MJ for 24hr, 48hr and 72hr, 
PI stained and analyzed through flow cytometry.
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Fig 15: Flow cytometry with CJ on LNCaP. CJ induced apoptosis in dose and 
time dependent manner in LNCaP cells, exposed to CJ for 24hr, 48hr and 72hr, 
PI stained and analyzed through flow cytometry.
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Fig 16: In vitro lipoxygenase assay, MJ and CJ tested at the concentrations 
Indicated for their effects on 5-LO and 15-LO enzymes. The error bars represent 
the standard deviation of the means (n=2).
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Fig 17; In vitro lipoxygenase assay, MJ tested at concentrations indicated for its 
effect on 5-LO and 15-LO enzymes. The error bars represent the standard 
deviation of the means (n=2).
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Fig 18: Alamar blue assay with 5-HETE. 2 mM MJ tested in presence and 
absence of 0.001 mM 5-HETE for 24hrs on the proliferation of both PC3 and 
LNCaP cells, using alamar Blue assay. Each graph represents the average of 
two different experiments. The error bars represent the standard deviation of the 
means of two experiments.
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Fig 19: Caspase-3 assay with MJ on PCS. 2 mM MJ induced caspase-3 activity 
in the PCS cell lysates, using a fluorometric assay. PCS cells were exposed to 2 
mM MJ for the time indicated and the cell lysates were tested for caspase-S 
activity by adding the caspase-S substrate conjugate.
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Fig 20: Caspase-3 assay with CJ on PCS. 2 mM CJ induced caspase-3 activity in 
the PCS cell lysates, using a fluorometric assay. PCS cells were exposed to 2 
mM CJ for the time indicated and the cell lysates were tested for caspase-S 
activity by adding the caspase-S substrate conjugate.
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CHAPTER 5 
CONCLUSIONS
The two plant stress hormones methyl jasmonate (MJ) and els jasmone 
(CJ) tested in this study, induced cell death in both hormone dependent (LNCaP) 
and hormone independent (PC3) human prostate cancer cell lines. MJ and CJ 
also inhibited the proliferation of PC3 and LNCaP cells. Inhibition of proliferation 
and cell death were confirmed by cytotoxicity assays using alamarBlue. The 
IC500/0 concentrations calculated from the alamar Blue assay showed that MJ and 
CJ are more lethal in LNCaP than PC3. CJ was shown to be more lethal than MJ 
in LNCaP but not in PC3 cells.
Cell cycle analysis using flow cytometry showed that both MJ and CJ at 1 
mM, 2 mM and 3 mM concentrations induced an S-phase block and apoptosis in 
PC3 cells. In LNCaP cells both MJ and CJ at 1 mM, 2 mM and 3 mM 
concentrations induced apoptosis in a dose dependent manner. Flow cytometry 
showed no cell cycle arrest in LNCaP cells with either MJ or CJ.
Recent research indicated that the ecosanoid products of arachidonic acid 
metabolism especially the 5-HETE is essential for prostate cancer progression 
[28]. 5-LO is an important and key enzyme in the arachidonic acid pathway 
involved in the production of 5-HETE [25]. We tested whether MJ or CJ were
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involved in inhibiting the 5-LO enzyme, thereby decreasing the production of 5- 
HETE and increasing the cell death. The in vitro Lipoxygenase assay with MJ 
and CJ confirms that both MJ and CJ do not inhibit the 5-LO enzyme and at the 
concentrations which we used for other assays in culture (1 mM, 2 mM and 3 
mM), only ~5% inhibition of 5-lipoxygenase by MJ was observed. These results 
indicate that MJ and CJ do not inhibit the 5-lipoxygenase enzyme. Experiments 
with 5-HETE and MJ on both PC3 and LNCaP cell lines showed that 5-HETE 
increased the viability of PC3 and LNCaP cells even in the presence of 2 mM MJ. 
This indicates that MJ is not involved in inhibiting the 5-LO enzyme and it does 
not act downstream of 5-HETE.
Finally, these results demonstrate that the hypothesis, MJ and CJ act via 
arachidonic acid metabolism and inhibit the 5-lipoxygenase, to be false (Figure 
21, page 52). These results do clearly indicate that both MJ and CJ induce 
apoptosis via the activation of caspase-3. Further studies will be required to 
determine the mechanism by which MJ and CJ induce apoptosis in prostate 
cancer lines.
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Fig 21; Conclusion, MJ and CJ activate caspase-3 and induce cell death in PC3 
and LNCaP prostate cancer cells.
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APPENDIX
Table 2: Cell cycle analysis with MJ on PC3 cell line
Time
Period
Treatment G0/G1 S G2/M Apoptosis
OmM 37.63±4.4 48.9912.1 13.4113.2 0.8710.3
1mM 58.73±0.8 22.5512.3 18.7211.9 1.2110.3
24hrs 2mM 36.64±1.0 51.8511.9 11.5111.6 7.3211.2
3mM 39.00±0.7 53.1810.6 7.8210.4 11.2311.5
OmM 511212 1 38.1513.6 10.7414.0 5.5611.9
48hrs 1mM 60.7211.8 22.3410.8 16.9511.5 5.1410.8
2mM 32.8711.3 52.1811.0 14.9610.7 5.5610.8
3mM 37.0211.0 48.4211.2 14.5611.1 12.8413.6
OmM 62.5911.8 27.9316.3 9.4815.4 7.3711.8
72hrs 1mM 71.2315.4 15.7013.3 13.0713.8 11.5711.7
2mM 40.8811.3 56.6611.7 2.4612.5 15.1812.5
3mM 37.6014.7 46.56112.8 15.8519.2 13.3712.0
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Table 3; Cell cycle analysis with CJ on PC3 cell line
Time
Period
Treatment G0/G1 S G2/M Apoptosis
OmM 32.23±2.7 49.4213.6 18.3511.1 0.0710.07
24hrs 1mM 26.44±2.7 65.0516.4 8.5014.3 1.9310.7
2mM 28.7511.5 70.9111.6 0.3510.1 1.9310.5
3mM 36.6710.5 62.4510.9 0 .8 8 1 0 . 6 11.9711.0
OmM 41.8110.9 27.3811.3 30.8110.8 1.5710.6
48hrs 1mM 30.7010.8 68.9510.8 0.3610.2 4.1710.9
2mM 33.4212.2 66.2512.0 0.3310.2 4.6810.7
3mM 35.8011.2 63.6311.3 0.5710.3 10.9212.3
OmM 45.0211.0 30.6211.8 24.3612.0 2.3710.6
72hrs 1mM 31.4111.0 64.2611.8 4.3412.0 4.8010.6
2mM 29.6511.2 57.6212.3 12.7313.2 5.5710.4
3mM 38.2211.1 61.3410.8 0.4510.4 23.6612.6
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Table 4: Cell cycle analysis with MJ on LNCaP cell line
Time
Period
Treatment G0/G1 S G2/M Apoptosis
24hrs
OmM
1mM
2mM
3mM
63.80±3.7
76.9211.4
60.27114.8
76.4311.1
35.4914.3 
15.2213.9 
37.47116.8
20.0413.3
0.7111.2
7.8612.9
2.2713.2
3.5313.1
0.4510.3
3.6911.2
2.1110.7
10.4113.3
48hrs
OmM
1mM
2mM
3mM
65.8117.1
82.7811.2
82.3314.4
77.6713.4
21.72115.8
0.92H.51
1.3311.66
16.7412.4
12.4818.7
16.3112.0
16.3413.9
5.5913.6
1.4611.7 
1.4310.6
5.9511.8 
6.9312.4
72hrs
OmM
1mM
2mM
3mM
75.8411.4
75.5714.4 
70.63111.8 
74.4415.0
5.7915.1
20.4216.5
22.49116.4
24.2616.3
18.3714.2
4.0216.7
6.8814.7 
1.3011.5
0.3910.4
3.2113.8
1.6211.2
4.4613.6
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Table 5: Cell cycle analysis with CJ on LNCaP cell line
Time
Period
Treatment G0/G1 S G2/M Apoptosis
OmM 66.8610.4 21.0810.6 12.0610.4 0.2310.1
24hrs 1mM 70.6910.5 10.8410.1 18.4710.4 0.7510.0
2mM 66.1311.1 15.7510.9 18.1210.2 5.7210.1
3mM 57.1311.6 38.9312.8 3.9412.5 32.7712.7
OmM 64.5411.4 21.9610.8 13.5110.7 0.2610.0
48hrs 1mM 72.4710.4 9.52l0.5 18.0110.3 1.6710.1
2mM 70.2511.3 16.1911.4 13.5610.9 12.2210.9
3mM 81.8417.5 4.8310.1 13.3316.1 50.7412.7
OmM 64.6711.1 17.3810.2 17.9611.0 0.1410.0
72hrs 1mM 72.4811.2 7.4711.8 20.0510.6 6.4012.0
2mM 74.0610.3 12.5410.3 13.4010.5 9.0010.4
3mM 78.7610.5 0.8110.4 20.4310.2 52.6113.7
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